{"id":45733,"date":"2021-06-03T15:01:49","date_gmt":"2021-06-03T13:01:49","guid":{"rendered":"https:\/\/haei.org\/?p=45733"},"modified":"2021-06-03T15:35:40","modified_gmt":"2021-06-03T13:35:40","slug":"oral-once-daily-orladeyo-now-available-in-germany","status":"publish","type":"post","link":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/","title":{"rendered":"Oral, once-daily Orladeyo now available in Germany"},"content":{"rendered":"<p>Oral, once-daily Orladeyo (berotralstat) from <strong>BioCryst Pharmaceuticals, Inc. <\/strong>was approved\u00a0by the European Medicines Agency (EMA) on 30 April 2021 for the prevention of recurrent HAE attacks in patients 12 years and older &#8211; and now the product is available for patients with a prescription in Germany.<\/p>\n<p>\u201cWe have an experienced team in place in Germany that is excited and honored to bring the first oral, once daily therapy to HAE patients in Europe,\u201d says Charlie Gayer, Chief Commercial Officer of BioCryst. \u201cPatients and physicians across Europe have told us about the significant need for a targeted oral therapy for HAE, and Germany is the first of many upcoming European launches for Orladeyo.\u201d<br \/>\n<em>(Source: BioCryst)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oral, once-daily Orladeyo (berotralstat) from BioCryst Pharmaceuticals, Inc. was approved\u00a0by the European Medicines Agency (EMA) on 30 April 2021 for the prevention of recurrent HAE attacks in patients 12 years and older &#8211; and now the product is available for patients with a prescription in Germany. \u201cWe have an experienced team in place in Germany [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":40709,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Oral, once-daily Orladeyo now available in Germany - HAE International (HAEi)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oral, once-daily Orladeyo now available in Germany - HAE International (HAEi)\" \/>\n<meta property=\"og:description\" content=\"Oral, once-daily Orladeyo (berotralstat) from BioCryst Pharmaceuticals, Inc. was approved\u00a0by the European Medicines Agency (EMA) on 30 April 2021 for the prevention of recurrent HAE attacks in patients 12 years and older &#8211; and now the product is available for patients with a prescription in Germany. \u201cWe have an experienced team in place in Germany [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\" \/>\n<meta property=\"og:site_name\" content=\"HAE International (HAEi)\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/haeinternational\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-03T13:01:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-03T13:35:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"765\" \/>\n\t<meta property=\"og:image:height\" content=\"565\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"PlusR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@haeday\" \/>\n<meta name=\"twitter:site\" content=\"@haeday\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"PlusR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\"},\"author\":{\"name\":\"PlusR\",\"@id\":\"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044\"},\"headline\":\"Oral, once-daily Orladeyo now available in Germany\",\"datePublished\":\"2021-06-03T13:01:49+00:00\",\"dateModified\":\"2021-06-03T13:35:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\"},\"wordCount\":119,\"publisher\":{\"@id\":\"https:\/\/haei.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"articleSection\":[\"HAEi News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\",\"url\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\",\"name\":\"Oral, once-daily Orladeyo now available in Germany - HAE International (HAEi)\",\"isPartOf\":{\"@id\":\"https:\/\/haei.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"datePublished\":\"2021-06-03T13:01:49+00:00\",\"dateModified\":\"2021-06-03T13:35:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage\",\"url\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"contentUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg\",\"width\":765,\"height\":565},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/haei.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oral, once-daily Orladeyo now available in Germany\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haei.org\/#website\",\"url\":\"https:\/\/haei.org\/\",\"name\":\"HAE International (HAEi)\",\"description\":\"HAE International (HAEi) is the global umbrella organization for the world\u2019s Hereditary Angioedema (HAE) patient groups.\",\"publisher\":{\"@id\":\"https:\/\/haei.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haei.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/haei.org\/#organization\",\"name\":\"HAE International\",\"url\":\"https:\/\/haei.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haei.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png\",\"contentUrl\":\"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png\",\"width\":162,\"height\":82,\"caption\":\"HAE International\"},\"image\":{\"@id\":\"https:\/\/haei.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/haeinternational\/\",\"https:\/\/x.com\/haeday\",\"https:\/\/www.linkedin.com\/company\/haei---international-patient-organization-for-c1-inhibitor-deficiencies\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044\",\"name\":\"PlusR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haei.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g\",\"caption\":\"PlusR\"},\"url\":\"https:\/\/haei.org\/author\/rikke\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oral, once-daily Orladeyo now available in Germany - HAE International (HAEi)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/","og_locale":"en_US","og_type":"article","og_title":"Oral, once-daily Orladeyo now available in Germany - HAE International (HAEi)","og_description":"Oral, once-daily Orladeyo (berotralstat) from BioCryst Pharmaceuticals, Inc. was approved\u00a0by the European Medicines Agency (EMA) on 30 April 2021 for the prevention of recurrent HAE attacks in patients 12 years and older &#8211; and now the product is available for patients with a prescription in Germany. \u201cWe have an experienced team in place in Germany [&hellip;]","og_url":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/","og_site_name":"HAE International (HAEi)","article_publisher":"https:\/\/www.facebook.com\/haeinternational\/","article_published_time":"2021-06-03T13:01:49+00:00","article_modified_time":"2021-06-03T13:35:40+00:00","og_image":[{"width":765,"height":565,"url":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","type":"image\/jpeg"}],"author":"PlusR","twitter_card":"summary_large_image","twitter_creator":"@haeday","twitter_site":"@haeday","twitter_misc":{"Written by":"PlusR","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#article","isPartOf":{"@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/"},"author":{"name":"PlusR","@id":"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044"},"headline":"Oral, once-daily Orladeyo now available in Germany","datePublished":"2021-06-03T13:01:49+00:00","dateModified":"2021-06-03T13:35:40+00:00","mainEntityOfPage":{"@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/"},"wordCount":119,"publisher":{"@id":"https:\/\/haei.org\/#organization"},"image":{"@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage"},"thumbnailUrl":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","articleSection":["HAEi News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/","url":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/","name":"Oral, once-daily Orladeyo now available in Germany - HAE International (HAEi)","isPartOf":{"@id":"https:\/\/haei.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage"},"image":{"@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage"},"thumbnailUrl":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","datePublished":"2021-06-03T13:01:49+00:00","dateModified":"2021-06-03T13:35:40+00:00","breadcrumb":{"@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#primaryimage","url":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","contentUrl":"https:\/\/haei.org\/wp-content\/uploads\/2020\/03\/news_biocryst.jpg","width":765,"height":565},{"@type":"BreadcrumbList","@id":"https:\/\/haei.org\/oral-once-daily-orladeyo-now-available-in-germany\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/haei.org\/"},{"@type":"ListItem","position":2,"name":"Oral, once-daily Orladeyo now available in Germany"}]},{"@type":"WebSite","@id":"https:\/\/haei.org\/#website","url":"https:\/\/haei.org\/","name":"HAE International (HAEi)","description":"HAE International (HAEi) is the global umbrella organization for the world\u2019s Hereditary Angioedema (HAE) patient groups.","publisher":{"@id":"https:\/\/haei.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haei.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/haei.org\/#organization","name":"HAE International","url":"https:\/\/haei.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haei.org\/#\/schema\/logo\/image\/","url":"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png","contentUrl":"https:\/\/haei.org\/wp-content\/uploads\/2018\/10\/logo.png","width":162,"height":82,"caption":"HAE International"},"image":{"@id":"https:\/\/haei.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/haeinternational\/","https:\/\/x.com\/haeday","https:\/\/www.linkedin.com\/company\/haei---international-patient-organization-for-c1-inhibitor-deficiencies\/"]},{"@type":"Person","@id":"https:\/\/haei.org\/#\/schema\/person\/12dbaca8bbeb196157bf0910f1b38044","name":"PlusR","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haei.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7cc04113a7d1f47ede71eb4d02f8e236?s=96&d=mm&r=g","caption":"PlusR"},"url":"https:\/\/haei.org\/author\/rikke\/"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"HAE International (HAEi)","distributor_original_site_url":"https:\/\/haei.org","push-errors":false,"_links":{"self":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts\/45733"}],"collection":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/comments?post=45733"}],"version-history":[{"count":0,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/posts\/45733\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/media\/40709"}],"wp:attachment":[{"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/media?parent=45733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/categories?post=45733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haei.org\/wp-json\/wp\/v2\/tags?post=45733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}